Diadema Partners LP Moderna, Inc. Call Options Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding MRNA
# of Institutions
874Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$668 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$652 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$464 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$195 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...